1. Home
  2. EPAC vs EVO Comparison

EPAC vs EVO Comparison

Compare EPAC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPAC
  • EVO
  • Stock Information
  • Founded
  • EPAC 1910
  • EVO 1993
  • Country
  • EPAC United States
  • EVO Germany
  • Employees
  • EPAC N/A
  • EVO N/A
  • Industry
  • EPAC Industrial Machinery/Components
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPAC Technology
  • EVO Health Care
  • Exchange
  • EPAC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • EPAC 2.3B
  • EVO 1.5B
  • IPO Year
  • EPAC N/A
  • EVO 2021
  • Fundamental
  • Price
  • EPAC $37.72
  • EVO $4.07
  • Analyst Decision
  • EPAC Buy
  • EVO Buy
  • Analyst Count
  • EPAC 1
  • EVO 2
  • Target Price
  • EPAC $53.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • EPAC 527.7K
  • EVO 113.1K
  • Earning Date
  • EPAC 06-26-2025
  • EVO 08-13-2025
  • Dividend Yield
  • EPAC 0.10%
  • EVO N/A
  • EPS Growth
  • EPAC 7.49
  • EVO N/A
  • EPS
  • EPAC 1.63
  • EVO N/A
  • Revenue
  • EPAC $608,099,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • EPAC $6.24
  • EVO $10.08
  • Revenue Next Year
  • EPAC $5.86
  • EVO $10.99
  • P/E Ratio
  • EPAC $23.38
  • EVO N/A
  • Revenue Growth
  • EPAC 2.82
  • EVO 1.50
  • 52 Week Low
  • EPAC $36.78
  • EVO $2.84
  • 52 Week High
  • EPAC $51.91
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • EPAC 29.79
  • EVO 47.66
  • Support Level
  • EPAC $37.33
  • EVO $4.12
  • Resistance Level
  • EPAC $38.54
  • EVO $4.26
  • Average True Range (ATR)
  • EPAC 1.31
  • EVO 0.11
  • MACD
  • EPAC -0.37
  • EVO -0.01
  • Stochastic Oscillator
  • EPAC 4.75
  • EVO 54.84

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: